Cocoon Bioscience produces recombinant proteins and enzymes for individual protein, nutrition, and healthcare applications.
Cocoon Bioscience has raised $2.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Cocoon Bioscience's investors include Columbus Venture Partners, BeAble Capital, Algenex, Cleon Capital, Gestion De Capital Riesgo Del Pais Vasco.
Cocoon Bioscience is headquartered in Madrid, Spain.
Cocoon Bioscience produces recombinant proteins and enzymes for individual protein, nutrition, and healthcare applications.
Cocoon Bioscience is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cocoon Bioscience — Funding & Investors." VCBacked, November 3, 2023, https://www.vcbacked.co/company/cocoon-bioscience. Accessed September 30, 2026.
VCBacked. (2023). Cocoon Bioscience — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cocoon-bioscience
{{cite web |title=Cocoon Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/cocoon-bioscience |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated